Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,993,489 papers from all fields of science
Search
Sign In
Create Free Account
Zometa
Known as:
Novartis brand of zoledronic acid
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
5 ML zoledronic acid 0.8 MG/ML Injection [Zometa]
Broader (2)
zoledronate
zoledronic acid
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
A Case Report of Two Primary Cancers, Breast Cancer with Adrenal Gland Metastatic and Second Primary Neuroendocrine Tumor in Colon, a Rare Case in Al-Bashir Hospital
S. Shamoun
,
A. Shamout
2018
Corpus ID: 80313227
A 68 years old female, was diagnosed as a case of right breast cancer in 2013; grade II/III according to Bloom Richardson grading…
Expand
2012
2012
Zometa (Zoledronic acid) and Myeloma patients
L. Firth
2012
Corpus ID: 30276414
Background: Physicians in Asia have anecdotally reported that Asian patients with multiple myeloma (MM) are frequently intolerant…
Expand
2011
2011
P1-18-01: Z-ACT1: Zometa Combined with Standard Therapy in Patients with Metastatic Breast Cancer Further Decreases the Proportion of Patients with CTC Counts of 5 or above.
A. Brufsky
,
J. Beck
,
+6 authors
K. Culver
2011
Corpus ID: 75868813
Introduction: Zoledronic acid (ZOL) has been shown to reduce the risk of recurrence and residual tumor size in the adjuvant…
Expand
2008
2008
Zoledronic acid (ZOMETA): a significant improvement in the treatment of Bone metastases
Z. Nagy
Pathology and Oncology Research
2008
Corpus ID: 19270454
Bone metastases are frequent complications of breast, lung and prostate cancers, multiplex myeloma, and less frequently of other…
Expand
2008
2008
Copyright by the American Dental Hygienists ' Association Bisphosphonates and Osteonecrosis of the Jaw ( ONJ )
Gregg S. Kuo
,
Y. Freeman
,
J. L. Goodwin
2008
Corpus ID: 28752293
Background. Recent reports have identified an association between osteonecrosis of the jaw or facial bones and treatment with…
Expand
2006
2006
[Acute kidney failure caused by zoledronic acid (Zometa)].
J. M. Peña
,
C. Vicente
,
R. Pernaute
,
P. Vives
Nefrología
2006
Corpus ID: 38642791
2006
2006
Fracaso renal agudo inducido por ácido zoledrónico (zometa)
P. Jm
,
C. Vicente
,
R. Pernaute
,
P. Vives
2006
Corpus ID: 77505111
2005
2005
Prävention und Behandlung partikelbedingter Osteolysen durch Zoledronat Zometa: Eine tierexperimentelle Studie
C. Wedemeyer
2005
Corpus ID: 86696524
The most common cause of implant failure in joint replacement is aseptic loosening due to particle-induced osteolysis. We…
Expand
2002
2002
FDA approves ZOMETA for treatment of cancer-related bone complications.
Expert Review of Anticancer Therapy
2002
Corpus ID: 36589229
2002
2002
Zoledronic Acid (Zometa
S. Kav
2002
Corpus ID: 208433413
This patient information was developed by Via Oncology, LLC © 2019. This information is not intended to be used as a substitute…
Expand